33443951|t|Brain 18F-FDG and 18F-Flumetamol PET Imaging of Fragile X-Associated Tremor Ataxia Syndrome.
33443951|a|ABSTRACT: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a rare movement disorder caused by a 55-to-200 CGG-trinucleotide expansion premutation in the FMR1 gene. Core diagnostic criteria are tremor, ataxia, and T2-weighted hyperintensity of the middle cerebellar peduncles on MRI, but FXTAS encompass a broad spectrum of neurological symptoms. FXTAS pathophysiology is largely unknown, and some animal models and neuropathology findings suggest possible overlap with Alzheimer disease. We report the combined PET imaging of a genetically confirmed FXTAS patient, presenting reduced temporal-frontal 18F-FDG uptake, and pathological cortical deposition of amyloid to 18F-flumetamol PET scan. This report may offer clues to FXTAS pathophysiology.
33443951	6	13	18F-FDG	Chemical	MESH:D019788
33443951	18	32	18F-Flumetamol	Chemical	-
33443951	48	91	Fragile X-Associated Tremor Ataxia Syndrome	Disease	MESH:C564105
33443951	103	146	Fragile X-associated tremor/ataxia syndrome	Disease	MESH:C564105
33443951	148	153	FXTAS	Disease	MESH:C564105
33443951	165	182	movement disorder	Disease	MESH:D009069
33443951	252	256	FMR1	Gene	2332
33443951	292	298	tremor	Disease	MESH:D014202
33443951	300	306	ataxia	Disease	MESH:D001259
33443951	386	391	FXTAS	Disease	MESH:C564105
33443951	422	443	neurological symptoms	Disease	MESH:D009461
33443951	445	450	FXTAS	Disease	MESH:C564105
33443951	568	585	Alzheimer disease	Disease	MESH:D000544
33443951	649	654	FXTAS	Disease	MESH:C564105
33443951	655	662	patient	Species	9606
33443951	700	707	18F-FDG	Chemical	MESH:D019788
33443951	756	763	amyloid	Disease	MESH:C000718787
33443951	767	781	18F-flumetamol	Chemical	-
33443951	823	828	FXTAS	Disease	MESH:C564105
33443951	Association	MESH:C564105	2332
33443951	Negative_Correlation	MESH:D019788	MESH:C564105

